GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: IWY-357 | NVP-IWY357
Compound class:
Synthetic organic
Comment: IWY357 is an orally bioavailable compound with antimalarial activity [2]. It is one of the antimalarials in the Medicine's for Malaria Venture (MMV) pipeline (link here) and is intended as a treatment for uncomplicated malaria with potential for resistance management. The chemical structure for IWY357 was revealed in the "First Time Disclosures" session at the ACS (Fall) 2024 meeting in Denver and it is one of the structures claimed in patent WO2023180964A1 [1]. The mechanism of action of IWY357 is not fully resolved.
The Malaria tab on this ligand page provides additional curator comments of relevance to the Guide to MALARIA PHARMACOLOGY. |
|
|||||||||||||||||||||||||||||||||||
| Guide to Malaria Pharmacology Comments |
| Targets the parasite at asexual blood stages. Potential Target/Mechanism Of Action: As the precise mechanism of action of IWY357 is not yet known, we do not have a molecular target for this compound. |
| Target Candidate Profiles | ||||
| Profile | Intended Use | Target Stage | Comment | References |
| TCP-1 | reduce parasite burden | asexual blood stages | ||